|
|
|
Volumn 24, Issue 6, 2015, Pages 19-
|
|
Biogen's aducanumab raises hope that Alzheimer's can be treated at its source
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADUCANUMAB;
AMYLOID BETA PROTEIN;
MONOCLONAL ANTIBODY;
NEW DRUG;
AGED;
ALZHEIMER DISEASE;
ANTAGONISTS AND INHIBITORS;
FEMALE;
HUMAN;
MALE;
PLAQUE, AMYLOID;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
AGED;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DRUGS, INVESTIGATIONAL;
FEMALE;
HUMANS;
MALE;
PLAQUE, AMYLOID;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 84939459267
PISSN: 10623388
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|